Cart

0

Stocks

“Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion”

Vertex Pharmaceuticals VRTX -0.02%decrease; red down pointing triangle has agreed to acquire Alpine Immune Sciences ALPN -0.01%decrease; red down pointing triangle for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue to heat up.

The companies said Wednesday that Vertex would pay $65 a share for Alpine. Net of expected cash to be acquired the deal is valued at roughly $4.6 billion. The acquisition is the largest in Vertex’s history, a spokeswoman for Vertex said…”

https://www.wsj.com/health/healthcare/vertex-pharmaceuticals-to-acquire-alpine-immune-sciences-for-4-9-billion-7edbeaeb?siteid=yhoof2

Leave a Reply